Sleep and Substance Use and Abuse in Adolescents

Child and Adolescent Psychiatric Clinics of North America

Volumn 18, Issue 4, 2009, Pages 929-946

  Gromov, Irina ^a   Gromov, Dmitriy ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Adolescent; Children; Sleep; Sleep disorders; Substance absue; Substance use

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE DERIVATIVE; ANABOLIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; DEXAMPHETAMINE; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; ILLICIT DRUG; METHADONE; METHAMPHETAMINE; METHYLPHENIDATE; MORPHINE; NARCOTIC ANALGESIC AGENT; NON PRESCRIPTION DRUG; OXYCODONE; SEDATIVE AGENT; TRANQUILIZER;

ADOLESCENT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CIGARETTE SMOKING; CIRCADIAN RHYTHM; COMORBIDITY; CONDUCT DISORDER; DAYTIME SOMNOLENCE; DEPRESSION; DRUG DEPENDENCE; HUMAN; INSOMNIA; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; SLEEP APNEA SYNDROME; SLEEP DISORDER; SUBSTANCE ABUSE;

ADOLESCENT; ALCOHOL DRINKING; CHILD; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MASS SCREENING; PRESCRIPTION DRUGS; SLEEP DISORDERS; SLEEP INITIATION AND MAINTENANCE DISORDERS; SMOKING; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 70349885456     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chc.2009.04.004     Document Type: Review

References (94)

1. Roane B.M., and Taylor D.J. Adolescent insomnia as a risk factor for early adult depression and substance abuse. Sleep 31 10 (2008) 1353-1356
2. Substance Abuse and Mental Health Services Administration (SAMHSA). Office of applied studies, national survey on drug use and health. 2008. Available at: (2007). www.oas.samphsa.gov Accessed October 1, 2009
3. Shibley H.L., Malcolm R.J., and Veatch L.M. Adolescents with insomnia and substance abuse: consequences and comorbidities. J Psychiatr Pract 13 3 (2008) 146-153
4. Roberts R.E., Roberts C.R., and Duong H.T. Chronic insomnia and its negative consequences for health and functioning in adolescents: a 12-month prospective study. J Adolesc Health 42 3 (2008) 294-302
5. Johnson E.O., and Breslaw N. Sleep problems and substance use in adolescents. Drug Alcohol Depend 64 (2001) 1-7
6. Ivanenko A., Crabtree V.M., and Gozal D. Sleep in children with psychiatric disorders. Pediatr Clin North Am 51 (2004) 51-68
7. Gau S.S., Shang C.Y., Merikangas K.R., et al. Association between morningness- eveningness and behavioral/emotional problems among adolescents. J Biol Rhythms 22 3 (2007) 268-274
8. Husler B.P., Bootzin R.R., Cousins J.C., et al. Circadian phase in sleep-disturbed adolescents with a history of substance abuse: a pilot study. Behav Sleep Med 6 (2008) 55-73
9. Bootzin R.R., and Stevens S.J. Adolescents, substance abuse, and the treatment of insomnia and daytime sleepiness. Clin Psychol Rev 25 (2005) 629-644
10. Tynjala J., Kanns L., and Levalahti E. Perceived tiredness among adolescents and its association with sleep habits and use of psychoactive substances. J Sleep Res 6 30 (1997) 189-198
11. Wong M.M., Brower K.J., Fitzgerald H.D., et al. Sleep problems in early childhood and early onset of alcohol and other drug use in adolescents. Alcohol Clin Exp Res 28 4 (2004) 578-587
12. Pine D.S., and Freedman R. Child psychiatry growin' up. Am J Psychiatry 166 1 (2009) 4-7
13. Sobanski E., Schredl M., Kettler N., et al. Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study. Sleep 31 3 (2008) 375-381
14. Wong M.M., Brower K.J., and Zucker R.A. Childhood sleep problems, early onset of substance use and behavioral problems in adolescence. Sleep Med 10 7 (2009) 787-796
15. Haynes P.L., Bootzin R.R., Smith L., et al. Sleep and aggression in substance-abusing adolescents: results from an integrative behavioral sleep-treatment pilot program. Sleep 29 4 (2006) 512-520
16. Wachter K. Risk factors identified for early heavy drinking. Clinical Psychiatry News 36 9 (2008) 27
17. Saarenpaa-Heikkila O., Laippala P., and Koivikko M. Subjective daytime sleepiness and its predictors in Finnish adolescents in an interview study. Acta Paediatr 90 5 (2001) 552-557
18. Midanik L.T., Tam T.W., and Weisner C. Concurrent and simultaneous drug and alcohol abuse: results of the 2000 National Alcohol Survey. Drug Alcohol Depend 90 1 (2007) 72-80
19. Roberts R.E., Roberts C.R., and Xing Y. Comorbidity of substance use disorders and other psychiatric disorders among adolescents: evidence from an epidemiologic survey. Drug Alcohol Depend 88 Suppl 1 (2007) S4-13
20. Swahn M.H., and Bossarte R.M. Gender, early alcohol use, and suicide ideation and attempts: findings from the 2005 youth risk behavior survey. J Adolesc Health 41 2 (2007) 175-181
21. Hingston R.W., Heeren T., and Winter M.R. Age of alcohol-dependence onset: associations with severity of dependence and seeking treatment. Pediatrics 118 3 (2006) e755-e763
22. Marshal M.P., Molina B.S., Pelham W.E., et al. Attention-deficit hyperactivity disorder moderates the life stress pathway to alcohol problems in children of alcoholics. Alcohol Clin Exp Res 31 4 (2007) 564-574
23. Molina B.S., Pelham W.E., Gnagy E.M., et al. Attention-deficit/hyperactivity disorder risk for heavy drinking and alcohol use disorder is age specific. Alcohol Clin Exp Res 31 (2007) 643-654
24. Brower K.J. Alcohol's effects on sleep in alcoholics. Alcohol Res Health 25 2 (2001) 110-125
25. Brower K.J., Akdrich M.S., Robinson E.A.R., et al. Insomnia, self-medication, and relapse to alcoholism. Am J Psychiatry 158 (2001) 399-404
26. Johston L.D., O'Malley P.M., Bachman J.G., et al. Various stimulant drugs show continuing declines among teens in 2008, most illicit drugs hold steady (2008), University of Michigan News Service, Ann Arbor (MI). http://www.monitoringthefuture.org Accessed October 1, 2009
27. Holmen T.L., Barett-Connor E., and Holmen J. Health problems in teenage daily smokers versus nonsmokers, Norway, 1995-1997: the Nord-Trondelag Health Study. Am J Epidemiol 151 2 (2000) 148-155
28. Mathers M., Toumbourou J.W., Catalano R.F., et al. Consequences of youth tobacco use: a review of prospective behavioral studies. Addiction 101 7 (2006) 948-958
29. Patten C.A., Choi W.S., Gillin C., et al. Depressive symptoms and cigarette smoking predict development and persistence of sleep problems in US adolescents. Pediatrics 106 2 (2000) 1-9
30. Phillips B.A., and Danner F.J. Cigarette smoking and sleep disturbance. Arch Intern Med 155 7 (1995) 734-737
31. Shin C., Joo S., Kim J., et al. Prevalence and correlates of habitual snoring in high school students. Chest 124 5 (2003) 1709-1715
32. Schrand J.R. Is sleep apnea a predisposing factor for tobacco use?. Med Hypotheses 47 6 (1996) 443-448
33. Morgan K.J., Stults V.J., and Zabnik M.E. Amount and dietary sources of caffeine and saccharin intake by individuals ages 5 to 18 years. Regul Toxicol Pharmacol 2 (1982) 296-307
34. Ellison R.C., Singer M.R., Moore L.L., et al. Current caffeine intake of young children: amount and sources. J Am Diet Assoc 95 (1995) 802-804
35. Strain E.C., Mumford G.K., Silverman K., et al. Caffeine dependence syndrome. Evidence from case histories and experimental evaluation. JAMA 272 (1994) 1043-1048
36. Crouch B.J., Caravati E.M., and Booth J. Trends in child and teen nonprescription drug abuse reported to a regional poison control center. Am J Health Syst Pharm 61 12 (2004) 1252-1257
37. Karacan I., Thornby J.I., Anch, et al. Dose-related sleep disturbances induced by coffee and caffeine. Clin Pharmacol Ther 20 6 (1976) 682-689
38. Pollak C.P., and Bright D. Caffeine consumption and weekly sleep patterns in US seventh-, eighth- and ninth-graders. Pediatrics 111 1 (2003) 42-46
39. Whalen D.J., Silk J.S., Semel M., et al. Caffeine consumption, sleep, and affect in the natural environments of depressed youth and healthy controls. J Pediatr Psychol 33 4 (2008) 358-367
40. Schepis T.S., and Krishna-Sarin S. Characterizing adolescent prescription misusers: a population based study. J Am Acad Child Adolesc Psychiatry 47 7 (2008) 745-754
41. Substance Abuse and Mental Health Services Administration (SAMHSA). Office of applied studies. Drug Abuse Warning Network. The new DAWN report: national ED estimates. 2008. Available at: (2008). http://dawninfo.samhsa.gov Accessed October 1, 2009
42. Wu L.T., Pilowsky W.E., and Schlenger W.E. High prevalence of substance use disorders among adolescents who use marijuana and inhalants. Drug Alcohol Depend 78 (2005) 23-32
43. Compton W.M., and Volkow N.D. Major increase in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 81 2 (2006) 103-107
44. Dimsdale J.E., Norman D., DeJardin D., et al. The effect of opioids on sleep architecture. J Clin Sleep Med 3 1 (2007) 33-36
45. Kay D.C., Eisenstein R.B., Jasinski D.R., et al. Morphine effects on human REM state, waking state and NREM sleep. Psychopharmacologia 14 (1969) 404-416
46. Wang D., and Teichtahl H. Opioids, sleep architecture and sleep-disordered breathing. Sleep Med Rev 11 1 (2007) 35-46
47. Zito J.M., Safer D.J., Berg L.T., et al. A three-country comparison of psychotropic medication prevalence in youth. [comment]. Child Adolesc Psychiatry Ment Health 2 1 (2008) 26
48. Lambert N., and Hartsough C. Prospective study of tobacco smoking and substance dependence among samples of ADHD and non-ADHD subjects. J Learn Disabil 31 (1998) 533-544
49. Wilens T.E., and Biederman J. Alcohol, drugs, and attention-deficit/hyperactivity disorder: a model for the study of addictions in youth. J Psychopharmacol 20 (2006) 580-588
50. Biederman J., Monuteaux M.C., Mick E., et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med 36 (2006) 167-179
51. Milberger S., Biederman J., Faraone S.V., et al. Associations between ADHD and psychoactive substance use disorders: findings from a longitudinal study of high-risk siblings of ADHD children. Am J Addict 6 (1997) 318-329
52. Wilson J.J., and Levin F.R. Attention-deficit/hyperactivity disorder and early-onset substance use disorders. J Child Adolesc Psychopharmacol 15 (2005) 751-763
53. Wilens T. Attention-deficit/hyperactivity disorder and adolescent substance use disorders. In: Kaminer Y., and Bukstein O.G. (Eds). Adolescent substance abuse. Psychiatric comorbidity and high- risk behaviors (2008), Routledge, New York 203-204 209-10
54. Faraone S.V., and Wilens T. Does stimulant treatment lead to substance use disorders?. J Clin Psychiatry 11 Suppl 64 (2003) 9-13
55. Faraone S.V., Biederman J., Wilens T.E., et al. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Psychol Med 37 12 (2007) 1743-1752
56. Rubia K., Smith A.B., Halari R., et al. Disorder-specific dissociation of orbitofrontal dysfunction in boys with pure conduct disorder during reward and ventrolateral prefrontal dysfunction in boys with pure ADHD during sustained attention. Am J Psychiatry 166 1 (2009) 83-94
57. Jones A.P., Laurens K.R., Herba C.M., et al. Amygdala hypoactivity to fearful faces in boys with conduct problems and callous-unemotional traits. Am J Psychiatry 166 1 (2009) 95-102
58. Mannuzza S., Klein R.G., Truong N.L., et al. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry 165 (2008) 604-609
59. Shaw P., Sharp W.S., Morrison M., et al. Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder. Am J Psychiatry 166 1 (2009) 58-63
60. Wilens T.E., Adamson L., Monuteaux M.C., et al. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med 162 10 (2008) 916-921
61. Williams R.J., Goodale L.A., Shay-Fiddler M.A., et al. Methylphenidate and dextro-amphetamine abuse in substance-abusing adolescents. Am J Addict 13 (2004) 381-389
62. McCabe S.E., Teter C.J., and Boyd C.J. The use, misuse, and diversion of prescription stimulants among middle and high school students. Subst Use Misuse 39 (2004) 1095-1116
63. Low K.G., and Gendaszek A.E. Illicit use of psychostimulants among college students: a preliminary study. Psychol Health Med 7 (2002) 283-287
64. Schredl M., Alm B., and Sobanski E. Sleep quality in adult patients with attention deficit hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 257 3 (2007) 164-168
65. Cohen-Zion M., and Anconi-Israel S. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies. Sleep Med Rev 8 (2004) 379-402
66. Golan N., Shahar E., and Ravid G. Sleep disorders and day time sleepiness in children with attention deficit hyperactivity disorder. Sleep 27 (2004) 261-266
67. O'Brien L.M., Ivanenko A., Crabtree V.M., et al. Sleep disturbances in children with attention deficit hyperactivity disorder. Pediatr Res 54 (2003) 237-243
68. Picchietti D.L., Underwood D.J., Farris W.A., et al. Further studies on periodic limb movement disorders and restless leg syndrome in children with attention-deficit hyperactivity disorder. Mov Disord 14 (1999) 1000-1007
69. O'Brian L.M., Ivanenko A., Crabtree V.M., et al. The effect of stimulants on sleep characteristics in children with attention/hyperactivity disorder. Sleep med 4 4 (2003) 309-316
70. Backmund M., Meyer K., Henkel C., et al. Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients. J Addict Dis 24 4 (2005) 17-29
71. Popoviciu L., and Corfariu O. Efficacy and safety of midazolam in the treatment of night terrors in children. Br J Clin Pharmacol 16 Suppl 1 (1983) 97S-102S
72. Solowij N., and Michie P. Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?. J Psychiatry Neurosci 32 1 (2007) 30-52
73. Rais M., Cahn W., Van Haren N., et al. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am J Psychiatry 165 4 (2008) 490-496
74. Murillo-Rodriguez E., Blanco-Centurion C., Sanchez C., et al. Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. Sleep 26 (2003) 943-947
75. Nicholson A.N., Turner C., Stone B.M., et al. Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 4 3 (2004) 305-313
76. Schierenbeck T., Riemann D., and Berger M. Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. Sleep Med Rev 12 (2008) 381-389
77. Dahl R.E., Scher M.S., Williamson D.E., et al. A longitudinal study of prenatal marijuana use. Effects on sleep and arousal at age 3 years. Arch Pediatr Adolesc Med 149 2 (1995) 145-150
78. Bolla K.I., Lesage M.D., Gamaldo C.E., et al. Sleep disturbance in heavy marijuana users. Sleep 31 6 (2008) 901-908
79. Vandrey R., Budney A.J., Kamon J.K., et al. Cannabis withdrawal in adolescent treatment seekers. Drug Alcohol Depend 78 2 (2005) 205-210
80. Dawes M.A., Liguori A., and Dougherty D.M. Cannabis withdrawal among adolescent cannabis users in an outpatient research setting. Am J Addict 15 6 (2006) 485-486
81. Smith D.E., Schwartz R.H., and Martin D.M. Heavy cocaine use in adolescents. Pediatrics 83 4 (1989) 539-542
82. Estroff T.W., Schwartz R.H., and Hoffman N.G. Adolescent cocaine abuse. Clin Pediatr 28 12 (1989) 550-555
83. McGregor C., Srisurapanont M., Jittiwutikarn J., et al. The nature, course and severity of methamphetamine withdrawal. Addiction 100 (2005) 1320-1329
84. Montoya A.G., Sorrentino R., and Lukas S.E. Long-term neuropsychiatric consequences of 'ecstasy' (NMDA): a review. Harv Rev Psychiatry 10 4 (2002) 212-220
85. de Win M.M., Reneman L., Jager G., et al. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology 32 2 (2007) 458-470
86. Bayen C.A., and Rosenberg H. A review of the acute subjective effects of MDMA/ecstasy. Addiction 101 7 (2006) 933-947
87. Sakai J.T., Hall S.K., Mikulich-Gilbertson, et al. Inhalant use, abuse, and dependence among adolescent patients: commonly comorbid problems. J Am Acad Child Adolesc Psychiatry 43 9 (2004) 1080-1088
88. Shah R., Vankar G.K., and Upadhyaya H.P. Phenomenology of gasoline intoxication and withdrawal symptoms among adolescents in India: a case series. Am J Addict 8 3 (1999) 254-257
89. Beaver K.M., Vaughn M.G., Delisi M., et al. Anabolic-androgenic steroid use and involvement in violent behavior in a nationally representative sample of young males in the United States. Am J Public Health 98 12 (2008) 2185-2187
90. Eklof A.C., Thurelius A.M., Garle M., et al. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol 59 8-9 (2003) 571-577
91. Daly R.C., Su T.P., Schmidt P.J., et al. Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findings. Arch Gen Psychiatry 58 2 (2001) 172-177
92. Liddle H.A., Dakof G.A., Turner R.M., et al. Treating adolescent drug abuse: a randomized trial comparing multidimensional family therapy and cognitive behavioral therapy. Addiction 103 10 (2008) 1660-1670
93. Volkow N.D. Stimulant medications: how to minimize their reinforcing effects?. Am J Psychiatry 163 (2006) 359-361
94. Johnson E.O., Roth T., Schultz L., et al. Epidemiology of DSM-IY insomnia in adolescence. Pediatrics 117 (2006) 247-256